InvestorsHub Logo
Followers 10
Posts 2572
Boards Moderated 0
Alias Born 03/01/2019

Re: SHEEPWOLF post# 1178

Friday, 03/29/2019 9:09:54 AM

Friday, March 29, 2019 9:09:54 AM

Post# of 2280
Check this out Sheepwolf.

The key takeaway for investors
Probably the most important thing for investors to know from Brightfield Group's report is that Europe could be more important to marijuana producers than Canada will be in the not-too-distant future. For investors seeking marijuana stocks that are most likely to succeed over the long run, look for the ones that have a head start in Europe (and in the U.S. as well).
Aurora Cannabis currently has the highest European sales, followed closely by Canopy Growth. Tilray is another major player in Europe, with the company's partnership with Novartis possibly giving it an advantage in winning market share for its medical cannabis products. Other Canadian marijuana producers also have European operations, including Aphria and Cronos Group.
The leaders in Europe, for now, though, appear to be Aurora, Canopy, and Tilray. And with a combined cannabis and CBD market of nearly $10 billion up for grabs, it's good to be ahead of the pack in Europe.



Ill post the entire report in a min.

GO CHOOM
GO ACB